Evaluating the effect of new remedy IMOD (Imunomodulating Drug)in the treatment of adult patients with sever sepsis

INTERVENTION: Intervention group received mentioned treatments plus (Imunomodulating Drug)IMOD (only 10 mililitre/day infusion once over 1 hour for 14 days) IMOD is a new remedy drug which increases CD4 lymphocytes significantly in patients with AIDS. IMOD has strong anti‐inflammatory effects and induces immune system without any significant side effects.Patients recieved standard treatment for the time needed,for example DVT prophylaxy upto time the patientis is immobilized or lung protective strategies until patints needmechanical ventilatory support. CONDITION: Severe sepsis PRIMARY OUTCOME: Mortality SECONDARY OUTCOME: Morbidity measured using the following scores: ; SOFA:(Sequential Organ Function Assessment) ; ADL:(Activity of Daily Living) ; TISS:(Therapeutic Intervention Scoring System) Mortality INCLUSION CRITERIA: 1.severe sepsis2.APACHE(Acute physiologic and chronic health evaluation) Score>203.Less than 24 hours from the diagnosis of sepsis.